Are you feeling “Applied Therapeutics” after this class action lawsuit reminder?
Don’t be a victim of securities violations!
LOS ANGELES, CA / ACCESSWIRE / December 26, 2024 / The Schall Law Firm is here to remind you
Hey there, investors! Have you heard about the latest class action lawsuit against Applied Therapeutics, Inc.? If you haven’t, don’t worry – we’ve got you covered. The Schall Law Firm, a national shareholder rights litigation firm, is reminding investors of potential violations of the Securities Exchange Act of 1934 by Applied Therapeutics. If you’re one of those investors who purchased the Company’s securities between January 3, 2024, and December 2, 2024, it’s time to take action!
Now, you might be thinking, “What in the world is going on?” Well, let us break it down for you. The lawsuit alleges violations of 10(b) and 20(a) of the Securities Exchange Act of 1934, as well as Rule 10b-5 promulgated by the U.S. Securities and Exchange Commission. That’s a whole lot of legal jargon, but basically, it means that there may have been some shady business going on at Applied Therapeutics that could have impacted your investment.
So what should you do next? Well, if you purchased securities from Applied Therapeutics during the Class Period, you are encouraged to contact The Schall Law Firm before February 18, 2025. Don’t wait until it’s too late – take action now to protect your rights as an investor!
How will this affect you?
As an investor who purchased securities from Applied Therapeutics during the Class Period, this class action lawsuit reminder is a wake-up call to protect your rights and potentially recover any losses you may have incurred. By contacting The Schall Law Firm before the deadline, you can take steps to hold Applied Therapeutics accountable for any alleged violations and seek compensation for your investment.
How will this affect the world?
While this class action lawsuit may seem like just another legal battle in the world of investments, its impact goes beyond individual investors. By holding companies accountable for securities violations, such lawsuits help maintain integrity and transparency in the financial markets. This case against Applied Therapeutics serves as a reminder that unethical practices will not go unchecked, setting a precedent for corporate accountability and investor protection.
